VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Pharming Group N.V. (PHAR) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Biotechnology · market value about $915M · P/E 40.4 · revenue $387M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows